Abstracts

NONINVASIVE PLASMA GLYCOMIC AND METABOLIC BIOMARKERS OF POSTTREATMENT HIV CONTROL

Non-invasive biomarkers that predict HIV remission after antiretroviral therapy (ART) interruption are urgently needed. Such biomarkers can improve the safety of analytic treatment interruption (ATI) and provide mechanistic insights into the pathways involved in post-ART HIV control. We examined two ATI cohorts: 1) Philadelphia cohort: a cohort of 24 HIV+ ART-suppressed individuals; 2) ACTG cohort:…

PD-1 BLOCKADE ENHANCES THERAPEUTIC BENEFITS OF VACCINE IN A CHRONIC SIV/MACAQUE MODEL

Limitations to achieving a complete HIV-1 infection cure include failure to remove latent reservoirs, CD8 T cell dysfunction due to immune exhaustion, and failure to induce anti-viral CD8+ T cells in lymphoid tissue where most reservoirs persist, even under anti-retroviral therapy (ART). These findings warrant the development of strategies that can simultaneously reduce reservoir burden…

A PLACEBO-CONTROLLED ATI TRIAL OF HTI VACCINES IN EARLY TREATED HIV INFECTION

HTI is a novel HIV vaccine immunogen designed at redirecting cellular immune responses to HIV targets associated with viral control. The AELIX-002 trial (NCT03204617) was a randomized, single-center, placebo-controlled trial to evaluate the safety, immunogenicity and antiviral effect of DNA.HTI (D), MVA.HTI (M) and ChAdOx1.HTI (C) vaccines after discontinuation of ART in early-treated people living…

EFFECTS OF HIV AND AGING ON FUNCTIONAL CONNECTIVITY AND ANATOMY

The effects of HIV infection and aging on brain structural and functional connectivity and neuropsychological performance (NP) remains poorly understood. Understanding the effects of the virus using a lifespan perspective is vital for providing appropriate care to people living with HIV (PLWH). 297 virologically well-controlled (55 years old). Deep learning models identified where the largest…